1. Home
  2. AMCX vs SLDB Comparison

AMCX vs SLDB Comparison

Compare AMCX & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMCX
  • SLDB
  • Stock Information
  • Founded
  • AMCX 1980
  • SLDB 2013
  • Country
  • AMCX United States
  • SLDB United States
  • Employees
  • AMCX N/A
  • SLDB N/A
  • Industry
  • AMCX Cable & Other Pay Television Services
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AMCX Telecommunications
  • SLDB Health Care
  • Exchange
  • AMCX Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • AMCX 275.8M
  • SLDB 234.8M
  • IPO Year
  • AMCX 2011
  • SLDB 2018
  • Fundamental
  • Price
  • AMCX $5.85
  • SLDB $2.90
  • Analyst Decision
  • AMCX Sell
  • SLDB Strong Buy
  • Analyst Count
  • AMCX 5
  • SLDB 9
  • Target Price
  • AMCX $6.50
  • SLDB $15.67
  • AVG Volume (30 Days)
  • AMCX 441.3K
  • SLDB 1.6M
  • Earning Date
  • AMCX 05-09-2025
  • SLDB 05-19-2025
  • Dividend Yield
  • AMCX N/A
  • SLDB N/A
  • EPS Growth
  • AMCX N/A
  • SLDB N/A
  • EPS
  • AMCX N/A
  • SLDB N/A
  • Revenue
  • AMCX $2,380,086,000.00
  • SLDB N/A
  • Revenue This Year
  • AMCX N/A
  • SLDB N/A
  • Revenue Next Year
  • AMCX N/A
  • SLDB $569.02
  • P/E Ratio
  • AMCX N/A
  • SLDB N/A
  • Revenue Growth
  • AMCX N/A
  • SLDB N/A
  • 52 Week Low
  • AMCX $5.41
  • SLDB $2.45
  • 52 Week High
  • AMCX $18.58
  • SLDB $10.99
  • Technical
  • Relative Strength Index (RSI)
  • AMCX 39.11
  • SLDB 43.66
  • Support Level
  • AMCX $5.57
  • SLDB $2.52
  • Resistance Level
  • AMCX $6.72
  • SLDB $3.05
  • Average True Range (ATR)
  • AMCX 0.33
  • SLDB 0.43
  • MACD
  • AMCX 0.01
  • SLDB -0.02
  • Stochastic Oscillator
  • AMCX 24.35
  • SLDB 20.77

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: